Pfizer has reached an $894 million deal to end most of the lawsuits over its two prescription pain relievers, the popular Celebrex and a similar drug, Bextra, no longer on the market.
The world's biggest drugmaker said Friday it has agreements in principle to end more than 90 percent of personal injury lawsuits brought by people claiming the pills caused heart attacks, strokes or other harm.
Pfizer hopes to settle those suits, which cover up to 92 percent of plaintiffs, by year's end. It also hopes to include many of the remaining claimants in the settlement and willfight any remaining personal injury suits with court motions or at trial, General Counsel Amy Schulman told The Associated Press.
More
No comments:
Post a Comment